Quantifying the basal insulin treatment preferences of people living in Canada with type 2 diabetes when glycemic control and cost are held constant: A discrete choice experiment

Key Points

• Treatment preferences for basal insulin vary among individuals with type 2 diabetes in Canada.
• Participants showed a notable inclination toward cost-effective options when glycemic control was stable.
• Analysis used a discrete choice experiment to assess choices on insulin therapy among adults.
• Findings underscore the importance of incorporating patient preferences into diabetes management plans.